Service de Médecine Interne, Clinic of Anemia, Hôpitaux Universitaires de Strasbourg (HUS), France
*Corresponding author:Emmanuel Andrès, Service de Médecine Interne, Clinic of Anemia, Hôpitaux Universitaires de Strasbourg (HUS), Strasbourg, Frances
Submission:September 26, 2026;Published: October 28, 2026
ISSN: 2577-2015Volume6 Issue2
Iron deficiency, with or without anaemia, is one of the most common and most persistently under-recognised medical conditions affecting women of reproductive age. Its two leading mechanistic pathways are gynaecological - chronic or acute menstrual and uterine blood loss - and obstetric - the greatly increased iron requirement of pregnancy compounded by peripartum blood loss. This Seminar reviews the principal gynaecological causes of iron deficiency, structured around the FIGO PALM-COEIN classification of abnormal uterine bleeding, with particular attention to uterine leiomyoma, adenomyosis, endometrial polyps, endometriosis, and bleeding disorders such as von Willebrand disease. It then reviews the obstetric causes, including the physiological iron cost of pregnancy, multiple gestation and short interpregnancy intervals, placental pathology, and postpartum haemorrhage, which together make pregnancy and the puerperium a period of maximal vulnerability to iron deficiency. We discuss current diagnostic thresholds and screening recommendations from FIGO, the American College of Obstetricians and Gynecologists, the World Health Organization, and the US Preventive Services Task Force, and we summarise the evidence base for oral iron, intravenous iron formulations, and hormonal and surgical treatments of the underlying gynaecological cause. Despite a high prevalence and well-documented adverse effects on quality of life, cognition, cardiovascular tolerance, and pregnancy outcome, iron deficiency in women remains frequently unrecognised because heavy menstrual bleeding is normalised by patients and under-elicited by clinicians. Systematic questioning about menstrual and obstetric history, coupled with routine ferritin measurement in at-risk women, is a simple intervention with the potential to substantially reduce the burden of this largely preventable and treatable condition.
a Creative Commons Attribution 4.0 International License. Based on a work at www.crimsonpublishers.com.
Best viewed in